Recent results of Duangkumpha et al. that studied the candidate proteins in sera of CCA patients compared to normal groups by mass spectrophotometry found statistically increasing levels of S100 calcium-binding protein A9 (S100A9) that had the potential to be used as the diagnostic biomarker of CCA patients [15]. Here, S100A9 is linked to cholangiocarcinoma.